Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

ConditionCesarean Section Complications

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexFemale

Age18-45

SponsorAswan University

About this trial

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

Eligibility criteria

Qualifiers

• Pregnant women aged 18-45 years.

ASA physical status II-III.

Disqualifiers

• Twin pregnancies.

Contraindications to spinal anesthesia (e.g., coagulopathy, infection).

Patients with incomplete preoperative data for risk stratification.

Trial design

Treatments tested in this trial

Hyperbaric Bupivacaine HCl 0.5% 12.5 mg
Hyperbaric Bupivacaine HCl 0.5% 10 mg

Treatment groups

333 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Aswan University

Lead sponsor

Source ClinicalTrials.gov